Profound Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Profound Medical stock has a consensus rating of "Strong Buy" and an average price target of $11.14. The average 1-year stock price forecast is 51.98% higher than the current stock price, while the lowest is $10 (+36.43%) and the highest is $12 (+63.71%).

Price Target: $11.14 (+51.98%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$11.14	$11.2	$12
Change	+36.43%	+51.98%	+52.80%	+63.71%

Analyst Ratings

The average analyst rating for Profound Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	May '26	Jul '26
Strong Buy	4	4	4	4	4	4
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Haynor Lake Street	Lake Street	Buy Reiterates $12	Buy	Reiterates	$12	+63.71%	Jul 7, 2026
Rick Wise Stifel Nicolaus	Stifel Nicolaus	Buy Reiterates $12 → $10	Buy	Reiterates	$12 → $10	+36.43%	May 8, 2026

Financial Forecast

Revenue This Year

26.24M

from 16.10M

63.03%

from 16.10M

Revenue Next Year

44.54M

from 26.24M

69.69%

from 26.24M

EPS This Year

-0.85

from -1.41

EPS Next Year

-0.76

from -0.85

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.87M	6.68M	7.20M	10.68M	16.10M	26.24M
Revenue Growth	-5.90%	-2.79%	7.75%	48.35%	50.73%	63.03%
Gross Profit	2.95M	3.02M	4.31M	7.04M	11.39M	18.41M
Gross Margin	42.95%	45.22%	59.90%	65.89%	70.77%	70.13%
Operating Income	-30.29M	-29.60M	-28.65M	-33.06M	-41.25M	-34.90M
Net Income	-30.70M	-28.67M	-28.32M	-27.82M	-42.57M	-31.61M
EPS	-	-	-	-	-1.41	-0.85
Free Cash Flow	-7.22M	-18.78M	-13.15M	-15.05M	-20.90M	1.87M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	29.5M
Avg	26.2M
Low	24.9M

Revenue Growth

Revenue Growth	2026	2027	2028
High	83.4%
Avg	63.0%
Low	54.4%

EPS Forecast

EPS	2026	2027	2028
High	-0.62
Avg	-0.85
Low	-0.95

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-